A 99% pure peptide that is contaminated with bacteria is not safe to inject regardless of its purity score
For instance, MC4-NN2-0453, which did not demonstrate clinical efficacy, achieved substantial peripheral circulation but may have had limited central penetrance
This history gives the platform clinical infrastructure and regulatory experience that newer GLP-1-only platforms lack, but weight management is not the platforms primary clinical focus
Additionally, post-operative patients exhibited lower levels of IGFBP-3, which correlated with an increased association with of CRC
The changes in the melanin index, moisture content of the stratum corneum, skin smoothness, skin elasticity and wrinkle formation were objectively assessed